Albiglutide is a new type of GLP-1 receptor agonist, which can activate the intracellular signal transduction system regulated by cell membrane-coupled G protein, repair and promote by binding to the GLP-1 receptor on the surface of islet β cells The function of pancreatic islet β cells increases insulin secretion, thereby reducing blood glucose concentration and glycated hemoglobin (Hb A1c) levels, and is an ideal drug for the treatment of type II diabetes. As early as April 15, 2014, the US Food and Drug Administration (FDA) officially approved the diabetes drug Albiglutide to be marketed as the second approved long-acting GLP-1 analog.
Storage:Cool dry place( Store at -20°C, away from the light)
Remark:For Research Use Only. Not for human use.
China
